Stereotactic body radiotherapy (SBRT)
Citation, DOI, disclosures and article data
At the time the article was created Henry Knipe had no recorded disclosures.View Henry Knipe's current disclosures
Stereotactic body radiotherapy (SBRT), also known as stereotactic ablative radiotherapy (SABR), is a technique used to treat certain cancers as an alternative to surgical resection. It can be used to treat early lung cancer and hepatocellular carcinoma.
- 1. White A, Swanson SJ. Surgery versus stereotactic ablative radiotherapy (SABR) for early-stage non-small cell lung cancer: less is not more. J Thorac Dis. 2016;8 (S4): S399-405. doi:10.21037/jtd.2016.04.40 - Free text at pubmed - Pubmed citation
- 2. Park SH, Kim JC, Kang MK. Technical advances in external radiotherapy for hepatocellular carcinoma. World J. Gastroenterol. 2016;22 (32): 7311-21. doi:10.3748/wjg.v22.i32.7311 - Free text at pubmed - Pubmed citation
- 3. Marcelo F. Benveniste, Daniel Gomez, Brett W. Carter, Sonia L. Betancourt Cuellar, Girish S. Shroff, Ana Paula A. Benveniste, Erika G. Odisio, Edith M. Marom. Recognizing Radiation Therapy–related Complications in the Chest. (2019) RadioGraphics. 39 (2): 344-366. doi:10.1148/rg.2019180061 - Pubmed